Flynn K, Hatfield J, Brown K, Vietor N, Hoang T
Front Endocrinol (Lausanne). 2025; 15():1479764.
PMID: 39845881
PMC: 11750692.
DOI: 10.3389/fendo.2024.1479764.
Levtchenko E, Ariceta G, Arguedas Flores O, Bichet D, Bockenhauer D, Emma F
Nat Rev Nephrol. 2024; 21(2):83-96.
PMID: 39438674
DOI: 10.1038/s41581-024-00897-z.
Kim G
J Clin Med. 2022; 11(19).
PMID: 36233678
PMC: 9572915.
DOI: 10.3390/jcm11195810.
Kramers B, Koorevaar I, van Gastel M, Goor H, Hallows K, Heerspink H
Clin J Am Soc Nephrol. 2022; 17(4):507-517.
PMID: 35314480
PMC: 8993480.
DOI: 10.2215/CJN.11260821.
Uchiyama K, Kitayama C, Yanai A, Ishibashi Y
Sci Rep. 2021; 11(1):17666.
PMID: 34480075
PMC: 8417075.
DOI: 10.1038/s41598-021-97113-w.
Ifosfamide-induced nephrogenic diabetes insipidus responsive to supraphysiologic doses of intravenous desmopressin.
Sohail M, Hassanein M, Rincon-Choles H
Clin Nephrol Case Stud. 2021; 9:87-92.
PMID: 34235046
PMC: 8259464.
DOI: 10.5414/CNCS110589.
Rapid development of vasopressin resistance in dietary K deficiency.
Al-Qusairi L, Grimm P, Zapf A, Welling P
Am J Physiol Renal Physiol. 2021; 320(5):F748-F760.
PMID: 33749322
PMC: 8174811.
DOI: 10.1152/ajprenal.00655.2020.
A patient with congenital nephrogenic diabetes insipidus due to AVPR2 mutation complicated by persisting polydipsia under hemodialysis treatment.
Iijima T, Mori T, Sohara E, Suwabe T, Hoshino J, Ubara Y
CEN Case Rep. 2020; 10(2):226-229.
PMID: 33125666
PMC: 8019439.
DOI: 10.1007/s13730-020-00549-8.
The Antidiuretic Effect of Diuretics in Diabetes Insipidus.
Lant A
J R Coll Physicians Lond. 2019; 2(3):298-309.
PMID: 30667783
PMC: 5370717.
Hydrochlorothiazide ameliorates polyuria caused by tolvaptan treatment of polycystic kidney disease in PCK rats.
Wang A, Hirose T, Ohsaki Y, Takahashi C, Sato E, Oba-Yabana I
Clin Exp Nephrol. 2018; 23(4):455-464.
PMID: 30426292
DOI: 10.1007/s10157-018-1669-9.
Case report: a thiazide diuretic to treat polyuria induced by tolvaptan.
Kramers B, van Gastel M, Meijer E, Gansevoort R
BMC Nephrol. 2018; 19(1):157.
PMID: 29970015
PMC: 6029076.
DOI: 10.1186/s12882-018-0957-7.
Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
Milano S, Carmosino M, Gerbino A, Svelto M, Procino G
Int J Mol Sci. 2017; 18(11).
PMID: 29125546
PMC: 5713354.
DOI: 10.3390/ijms18112385.
Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiology.
Bichet D, El Tarazi A, Matar J, Lussier Y, Arthus M, Lonergan M
Clin Kidney J. 2015; 5(3):195-202.
PMID: 26069764
PMC: 4400507.
DOI: 10.1093/ckj/sfs029.
A novel therapeutic effect of statins on nephrogenic diabetes insipidus.
Bonfrate L, Procino G, Wang D, Svelto M, Portincasa P
J Cell Mol Med. 2015; 19(2):265-82.
PMID: 25594563
PMC: 4407600.
DOI: 10.1111/jcmm.12422.
Efficacy of Hydrochlorothiazide and low renal solute feed in Neonatal Central Diabetes Insipidus with transition to Oral Desmopressin in early infancy.
Abraham M, Rao S, Price G, Choong C
Int J Pediatr Endocrinol. 2014; 2014(1):11.
PMID: 25002871
PMC: 4084573.
DOI: 10.1186/1687-9856-2014-11.
High-throughput chemical screening identifies AG-490 as a stimulator of aquaporin 2 membrane expression and urine concentration.
Nomura N, Nunes P, Bouley R, Nair A, Shaw S, Ueda E
Am J Physiol Cell Physiol. 2014; 307(7):C597-605.
PMID: 24944200
PMC: 4187055.
DOI: 10.1152/ajpcell.00154.2014.
Randomized, Double-Blind Clinical Trial to Assess the Acute Diuretic Effect of Equisetum arvense (Field Horsetail) in Healthy Volunteers.
Carneiro D, Freire R, Honorio T, Zoghaib I, Cardoso F, Tresvenzol L
Evid Based Complement Alternat Med. 2014; 2014:760683.
PMID: 24723963
PMC: 3960516.
DOI: 10.1155/2014/760683.
The long-term complications of the inherited tubulopathies: an adult perspective.
Khosravi M, Walsh S
Pediatr Nephrol. 2014; 30(3):385-95.
PMID: 24566812
DOI: 10.1007/s00467-014-2779-6.
THE ANTIDIURETIC ACTION OF HYDROCHLOROTHIAZIDE IN THE HYDRATED RAT.
DICKER S, EGGLETON M
J Physiol. 1964; 171:377-83.
PMID: 14193927
PMC: 1368837.
DOI: 10.1113/jphysiol.1964.sp007383.
Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor.
Pattaragarn A, Alon U
Pediatr Nephrol. 2003; 18(10):1073-6.
PMID: 12883974
DOI: 10.1007/s00467-003-1195-0.